The in vitro and in vivo effects of fluoxetine (and its active metabol
ite norfluoxetine) on mitochondrial respiration and F0F1-ATPase were s
tudied, respectively, in mitochondria and submitochondrial particles i
solated from rat liver. Fluoxetine in vitro inhibited state 3 mitochon
drial respiration for alpha-ketoglutarate and succinate oxidations (50
% of effect at 0.25 and 0.35 mM drug concentrations, respectively); st
imulated state 4 for succinate; and induced a decrease in the respirat
ory control ratio (RCR) for both oxidizable substrates. The F0F1-ATPas
e activity was determined at various pH levels in the absence and pres
ence of Triton X-100. The solubilized form was not affected markedly,
but an inhibition, apparently non-competitive, was observed for the me
mbrane-bound enzyme, with 50% of the effect at a 0.06 mM drug concentr
ation in pH 7.4. These results suggest that fluoxetine in vitro acts o
n F0F1-ATPase through direct interaction with the membrane F-0 compone
nt (similar to oligomycin), or first with mitochondrial membrane and t
hen affecting F-0. A very similar behavior concerning the respiratory
parameters and F0F1-ATPase properties was observed with norfluoxetine.
The in vivo studies with fluoxetine showed stimulation of mitochondri
al respiration in state 4 for alpha-ketoglutarate or succinate oxidati
ons in acute or prolonged treatments (1 hr after a single i.p. dose of
20 mg of drug/kg of body weight, and 22 hr after 12 days of treatment
with a daily dose of 10 mg/kg of body weight, respectively), indicati
ng uncoupling of oxidative phosphorylation. Pronounced changes were no
t observed in the K-0.5 values of F0F1-ATPase catalytic sites, but the
V-max decreased during the prolonged treatment. The results show that
fluoxetine (as well as norfluoxetine) has multiple effects on the ene
rgy metabolism of rat liver mitochondria, being potentially toxic in h
igh doses. The drug effects seem to be a consequence of the drug and/o
r metabolite solubilization in the inner membrane of the mitochondria.